CASP3 and chronic kidney disease: Thus, we quantified caspase 3 levels by immunofluorescence at P1 and detected significantly enhanced immunoreactivity in Kölliker’s organ of all cochlear turns in the Cx26-cKD group compared to controls (Figures 2C,D, P < 0.05, n = 3).